Atrás
18
Rango del Día
$34.01
$50.37
Rango de 52 Semanas
$28.66
$117.33
Volumen
11,718,296
Promedio 50D / 200D
$37.45
/
$64.86
Cierre Anterior
$33.82
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 43.2 | 0.3 |
| P/B | 6.7 | 3.0 |
| ROE % | 15.0 | 3.7 |
| Net Margin % | 13.1 | 3.8 |
| Rev Growth 5Y % | 20.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$68.40
+69.0%
Low: $30.00
High: $100.00
P/E Futuro
94.12
EPS Futuro
$0.36
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
884.47M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$8.40
$7.62 – $9.46
|
2.56B | 1 |
| FY2029 |
$6.13
$5.56 – $6.90
|
2.12B | 1 |
| FY2028 |
$2.89
$2.15 – $4.09
|
1.53B | 3 |
No quarterly estimates available
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 20.10% annually over 5 years — strong growth
Earnings declined -28.68% over the past year
ROE of 15.01% — decent returns on equity
Debt/Equity of 0.01 — conservative balance sheet
Generating 141.79M in free cash flow
P/E of 43.20 — premium valuation
Crecimiento
Revenue Growth (5Y)
20.10%
Revenue (1Y)12.79%
Earnings (1Y)-28.68%
FCF Growth (3Y)5.70%
Calidad
Return on Equity
15.01%
ROIC5.14%
Net Margin13.09%
Op. Margin5.88%
Seguridad
Debt / Equity
0.01
Current Ratio2.92
Interest Coverage0.00
Valoración
P/E Ratio
43.20
Forward P/E94.12
P/B Ratio6.65
EV/EBITDA93.55
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.79% | Revenue Growth (3Y) | 25.64% |
| Earnings Growth (1Y) | -28.68% | Earnings Growth (3Y) | -3.10% |
| Revenue Growth (5Y) | 20.10% | Earnings Growth (5Y) | -2.99% |
| Profitability | |||
| Revenue (TTM) | 761.41M | Net Income (TTM) | 99.65M |
| ROE | 15.01% | ROA | 11.91% |
| Gross Margin | 98.30% | Operating Margin | 5.88% |
| Net Margin | 13.09% | Free Cash Flow (TTM) | 141.79M |
| ROIC | 5.14% | FCF Growth (3Y) | 5.70% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 2.92 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 43.20 | Forward P/E | 94.12 |
| P/B Ratio | 6.65 | P/S Ratio | 5.65 |
| PEG Ratio | -1.22 | Forward PEG | N/A |
| EV/EBITDA | 93.55 | Fwd EV/EBITDA | 20.56 |
| Forward P/S | 4.87 | Fwd Earnings Yield | 1.06% |
| FCF Yield | 3.29% | ||
| Market Cap | 4.30B | Enterprise Value | 4.19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 761.41M | 675.04M | 482.38M | 401.86M | 365.98M |
| Net Income | 99.65M | 139.73M | 106.14M | 101.42M | 112.51M |
| EPS (Diluted) | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
| Gross Profit | 748.43M | 664.16M | 475.89M | 396.47M | 360.70M |
| Operating Income | 44.80M | 136.95M | 107.28M | 112.63M | 124.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 836.65M | 840.55M | 621.52M | 583.43M | 423.76M |
| Total Liabilities | 188.85M | 160.96M | 114.81M | 81.59M | 47.95M |
| Shareholders' Equity | 647.81M | 679.59M | 506.71M | 501.84M | 375.81M |
| Total Debt | 6.11M | 6.94M | 151,000.0 | 1.14M | 526,000.0 |
| Cash & Equivalents | 120.50M | 127.67M | 135.55M | 66.33M | 77.62M |
| Current Assets | 485.46M | 471.60M | 458.64M | 499.25M | 266.46M |
| Current Liabilities | 166.09M | 140.77M | 104.51M | 72.49M | 47.54M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#1001 of 1052
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026